Hap Trading, LLC Cure Vac N.V. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	SELL	$14.73 - $35.25 $1.31 Million - $3.12 Million	-88,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $26,976 - $38,576	-800 Reduced 0.89%	88,600 $2.27 Million
Q3 2021 Nov 10, 2021	SELL	$49.26 - $74.5 $29,556 - $44,700	-600 Reduced 0.67%	89,400 $1.22 Million
Q2 2021 Aug 11, 2021	BUY	$56.91 - $127.53 $3.27 Million - $7.33 Million	57,500 Added 176.92%	90,000 $1.29 Million
Q1 2021 May 14, 2021	SELL	$79.79 - $126.29 $263,307 - $416,757	-3,300 Reduced 9.22%	32,500 $121,000
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $1.67 Million - $4.88 Million	35,800 New	35,800 $497,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.